.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Moodys
Chinese Patent Office
Express Scripts
Federal Trade Commission
Colorcon
Boehringer Ingelheim
Mallinckrodt
Accenture
Deloitte

Generated: July 24, 2017

DrugPatentWatch Database Preview

Collegium Pharm Inc Company Profile

« Back to Dashboard

What is the competitive landscape for COLLEGIUM PHARM INC, and when can generic versions of COLLEGIUM PHARM INC drugs launch?

COLLEGIUM PHARM INC has one approved drug.

There are ten US patents protecting COLLEGIUM PHARM INC drugs.

There are fourteen patent family members on COLLEGIUM PHARM INC drugs in five countries.

Summary for Applicant: Collegium Pharm Inc

Patents:10
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Collegium Pharm Inc
XTAMPZA ER
oxycodone
CAPSULE, EXTENDED RELEASE;ORAL208090-002Apr 26, 2016RXYesNo► Subscribe► SubscribeY ► Subscribe
Collegium Pharm Inc
XTAMPZA ER
oxycodone
CAPSULE, EXTENDED RELEASE;ORAL208090-004Apr 26, 2016RXYesNo► Subscribe► SubscribeY ► Subscribe
Collegium Pharm Inc
XTAMPZA ER
oxycodone
CAPSULE, EXTENDED RELEASE;ORAL208090-001Apr 26, 2016RXYesNo► Subscribe► SubscribeY ► Subscribe
Collegium Pharm Inc
XTAMPZA ER
oxycodone
CAPSULE, EXTENDED RELEASE;ORAL208090-005Apr 26, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Collegium Pharm Inc
XTAMPZA ER
oxycodone
CAPSULE, EXTENDED RELEASE;ORAL208090-005Apr 26, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Collegium Pharm Inc Drugs

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2004004693► Subscribe
Australia2003247876► Subscribe
Canada2491572► Subscribe
European Patent Office1765292► Subscribe
Canada2916869► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Collegium Pharm Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
292Luxembourg► SubscribePRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Colorcon
McKinsey
Express Scripts
Johnson and Johnson
Harvard Business School
Citi
Baxter
Dow
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot